Save the Date
Overview
Join the Florida Society of Clinical Oncology (FLASCO) for a virtual educational webinar designed to equip oncology professionals with the knowledge and tools needed to become effective advocates for patients, providers, and the broader cancer care community. Presented by the FLASCO Legislative Committee in partnership with Pfizer Oncology, this 45-minute program will explore critical federal and state legislative issues shaping the future of oncology care, including Most Favored Nation (MFN) drug pricing policies, Medicare Advantage step therapy requirements, and opportunities to expand clinical trial access throughout Florida.
Featuring insights from Michelle Flowers, Founder of Oncology Managers of Florida; Patti Jewell-Fine of Pfizer; and Omar Rashid, MD, JD, FACS, FSSO, DABS, of the FLASCO Legislative Committee, the session will examine policy challenges, barriers to timely treatment, and opportunities for meaningful legislative engagement. Attendees will gain practical perspectives on navigating the evolving healthcare policy landscape, supporting patient access to care, and strengthening Florida’s role in clinical research. The program will conclude with an interactive Q&A and key advocacy takeaways.
Event Details
- Date: Tuesday, November 3, 2026
- Time: 5:00 – 5:45 PM ET
- Location: Virtual Educational Webinar
- Presented by: FLASCO Legislative Committee
- In Partnership with: Pfizer Oncology
Featured Sessions & Speakers
Most Favored Nation (MFN) Drug Pricing: Federal Policy & State Implications
Michelle Flowers, Founder of Oncology Managers of Florida
Medicare Advantage Step Therapy: Challenges & Advocacy Priorities
Patti Jewell-Fine, Pfizer
Expanding Clinical Trial Opportunities in Florida
Omar Rashid, MD, JD, FACS, FSSO, DABS, FLASCO Legislative Committee
The webinar will conclude with audience Q&A and closing remarks focused on actionable advocacy priorities for Florida’s oncology community, presented in partnership with Pfizer Oncology.
